BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 34272882)

  • 1. Risk of transfusion-transmitted Babesia microti in Canada.
    O'Brien SF; Drews SJ; Yi QL; Bloch EM; Ogden NH; Koffi JK; Lindsay LR; Gregoire Y; Delage G
    Transfusion; 2021 Oct; 61(10):2958-2968. PubMed ID: 34272882
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Characteristics of transfusion-transmitted Babesia microti, American Red Cross 2010-2017.
    Tonnetti L; Townsend RL; Dodd RY; Stramer SL
    Transfusion; 2019 Sep; 59(9):2908-2912. PubMed ID: 31250463
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Transfusion-transmitted Babesia spp.: bull's-eye on Babesia microti.
    Leiby DA
    Clin Microbiol Rev; 2011 Jan; 24(1):14-28. PubMed ID: 21233506
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Seroprevalence of Babesia microti infection in Canadian blood donors.
    O'Brien SF; Delage G; Scalia V; Lindsay R; Bernier F; Dubuc S; Germain M; Pilot G; Yi QL; Fearon MA
    Transfusion; 2016 Jan; 56(1):237-43. PubMed ID: 26426217
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lookback investigations of Babesia microti-seropositive blood donors: seven-year experience in a Babesia-endemic area.
    Johnson ST; Cable RG; Leiby DA
    Transfusion; 2012 Jul; 52(7):1509-16. PubMed ID: 21910741
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Screening for Babesia microti in the U.S. Blood Supply.
    Moritz ED; Winton CS; Tonnetti L; Townsend RL; Berardi VP; Hewins ME; Weeks KE; Dodd RY; Stramer SL
    N Engl J Med; 2016 Dec; 375(23):2236-2245. PubMed ID: 27959685
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prevalence of Babesia in Canadian blood donors: June-October 2018.
    Tonnetti L; O'Brien SF; Grégoire Y; Proctor MC; Drews SJ; Delage G; Fearon MA; Brès V; Linnen JM; Stramer SL
    Transfusion; 2019 Oct; 59(10):3171-3176. PubMed ID: 31385317
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Seroprevalence of Babesia microti in blood donors from Babesia-endemic areas of the northeastern United States: 2000 through 2007.
    Johnson ST; Cable RG; Tonnetti L; Spencer B; Rios J; Leiby DA
    Transfusion; 2009 Dec; 49(12):2574-82. PubMed ID: 19821951
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Transfusion-transmitted Babesia microti identified through hemovigilance.
    Tonnetti L; Eder AF; Dy B; Kennedy J; Pisciotto P; Benjamin RJ; Leiby DA
    Transfusion; 2009 Dec; 49(12):2557-63. PubMed ID: 19624607
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Transfusion-Transmitted Babesia microti.
    Fang DC; McCullough J
    Transfus Med Rev; 2016 Jul; 30(3):132-8. PubMed ID: 27260107
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Babesia microti in a Canadian blood donor and lookback in a red blood cell recipient.
    Drews SJ; Van Caeseele P; Bullard J; Lindsay LR; Gaziano T; Zeller MP; Lane D; Ndao M; Allen VG; Boggild AK; O'Brien SF; Marko D; Musuka C; Almiski M; Bigham M
    Vox Sang; 2022 Mar; 117(3):438-441. PubMed ID: 34462920
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Transmission of Babesia microti in Minnesota through four blood donations from the same donor over a 6-month period.
    Herwaldt BL; Neitzel DF; Gorlin JB; Jensen KA; Perry EH; Peglow WR; Slemenda SB; Won KY; Nace EK; Pieniazek NJ; Wilson M
    Transfusion; 2002 Sep; 42(9):1154-8. PubMed ID: 12430672
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Babesia blood testing: the first-year experience.
    Tonnetti L; Dodd RY; Foster G; Stramer SL
    Transfusion; 2022 Jan; 62(1):135-142. PubMed ID: 34726279
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Performance Evaluation of a Prototype Architect Antibody Assay for Babesia microti.
    Cheng K; Coller KE; Marohnic CC; Pfeiffer ZA; Fino JR; Elsing RR; Bergsma J; Marcinkus MA; Kar AK; Gumbs OH; Otis KS; Fishpaugh J; Schultz PW; Pope MR; Narvaez AR; Wong SJ; Madison-Antenucci S; Leary TP; Dawson GJ
    J Clin Microbiol; 2018 Aug; 56(8):. PubMed ID: 29743308
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The impact of Babesia microti blood donation screening.
    Tonnetti L; Townsend RL; Deisting BM; Haynes JM; Dodd RY; Stramer SL
    Transfusion; 2019 Feb; 59(2):593-600. PubMed ID: 30499595
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cost-effectiveness of blood donor screening for Babesia microti in endemic regions of the United States.
    Simon MS; Leff JA; Pandya A; Cushing M; Shaz BH; Calfee DP; Schackman BR; Mushlin AI
    Transfusion; 2014 Mar; 54(3 Pt 2):889-99. PubMed ID: 24252132
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Preventing transfusion-transmitted babesiosis: preliminary experience of the first laboratory-based blood donor screening program.
    Young C; Chawla A; Berardi V; Padbury J; Skowron G; Krause PJ;
    Transfusion; 2012 Jul; 52(7):1523-9. PubMed ID: 22452654
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Description of 15 DNA-positive and antibody-negative "window-period" blood donations identified during prospective screening for Babesia microti.
    Moritz ED; Tonnetti L; Hewins ME; Berardi VP; Dodd RY; Stramer SL
    Transfusion; 2017 Jul; 57(7):1781-1786. PubMed ID: 28453188
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Determination of Babesia microti seroprevalence in blood donor populations using an investigational enzyme immunoassay.
    Levin AE; Williamson PC; Erwin JL; Cyrus S; Bloch EM; Shaz BH; Kessler D; Telford SR; Krause PJ; Wormser GP; Ni X; Wang H; Krueger NX; Caglioti S; Busch MP
    Transfusion; 2014 Sep; 54(9):2237-44. PubMed ID: 24995863
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A fatal case of transfusion-transmitted babesiosis in the State of Delaware.
    Zhao Y; Love KR; Hall SW; Beardell FV
    Transfusion; 2009 Dec; 49(12):2583-7. PubMed ID: 19906041
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.